Women’s health

CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda

24 March 2024. Related: Conference reports, Treatment access, Women's health, Pregnancy, Vaccines and microbicides.

Modest increase in rate of cardiovascular disease progression during perimenopause for women living with HIV

1 December 2023. Related: Women's health.

Implications of restrictions on reproductive rights for HIV care in the USA and beyond

6 April 2023. Related: Conference reports, Treatment access, Women's health, Pregnancy.

Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192

1 September 2022. Related: Conference reports, Women's health.

CROI 2022: Higher maternal mortality and adverse birth outcomes among women with COVID-19 in Botswana

1 March 2022. Related: Conference reports, Women's health, Pregnancy.

Obesity linked to dolutegravir, especially with TAF, could increase risk of adverse pregnancy outcomes

22 July 2020. Related: Conference reports, Women's health, Pregnancy, Side effects.

Long-acting cabotegravir and rilpivirine: similar results in women and men

24 February 2020. Related: Conference reports, Antiretrovirals, Women's health.

Drug-drug interactions between efavirenz and levonorgestrel influenced by genetic variants

19 June 2019. Related: Conference reports, Women's health, PK and drug interactions.

Antiretroviral pharmacokinetics in pregnancy: update from IMPAACT P1026s

19 June 2019. Related: Conference reports, Women's health, Pregnancy, TB coinfection.

Importance of including menopause and bone health in management of HIV positive women

20 May 2019. Related: Conference reports, Women's health.

Double-dose levonorgestrel implant does not overcome interaction with efavirenz

28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.

Efavirenz and rifampicin together reduce levels of injectable contraception

28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.

High rate of unintended pregnancy among HIV positive African women on ART

19 September 2018. Related: Conference reports, Women's health, Pregnancy.

WHO recommends dolutegravir widely but women’s access will depend on contraception provision (2018)

3 August 2018. Related: Conference reports, Women's health, Pregnancy, Guidelines.

Dolutegravir: need to consider all pros and cons before switching in pregnancy

11 July 2018. Related: Women's health, Pregnancy.

Almost 1 in 8 people with symptoms turned away from sexual health clinics in SE London: 40% are under 25 and 6% under 18 years old

1 May 2018. Related: Conference reports, Treatment access, Women's health, Pregnancy, HIV prevention and transmission.

Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated

16 April 2018. Related: Conference reports, Women's health, Pregnancy, TB coinfection.

Screening HIV positive pregnant women for TB in South Africa increased detection by 10-fold

28 November 2017. Related: Conference reports, Women's health, Pregnancy, HIV prevention and transmission.

Experts disagree with controversial BMJ support for older HIV drugs in pregnancy

1 October 2017. Related: Special reports, Women's health, Pregnancy.

Dolutegravir is superior to boosted atazanavir in women in the ARIA study

1 August 2016. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Doravirine can be co-administered with oral contraceptives

1 June 2016. Related: Conference reports, Women's health.

Reducing efavirenz dose is unlikely to overcome interaction with levonorgestrel

1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.

Doravirine and cabotegravir do not affect the pharmacokinetics of oral contraceptives

1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, PK and drug interactions.

Low prolactin and high 20alpha-HSD might contribute to ART-associated progesterone deficits in pregnancy

1 June 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Adolescents at increased risk of vertical transmission and poor pregnancy outcome in South Africa

1 June 2015. Related: Conference reports, Women's health, Pregnancy.

Gender difference in virological response to ART

1 June 2015. Related: Conference reports, Antiretrovirals, Women's health.

Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART

24 March 2015. Related: Conference reports, Women's health, PK and drug interactions.

Gender differences in use of cardiovascular disease-related interventions: D:A:D study

1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.

Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents

1 December 2014. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Women, HIV research and antiretrovirals

1 February 2014. Related: Conference reports, Antiretrovirals, Women's health, Cure-related research.

Improved virological outcomes for women starting efavirenz-based first-line regimens in South Africa

1 February 2014. Related: Conference reports, Women's health.

High rates of pregnancy in HIV positive women in Zambia and South Africa

1 February 2014. Related: Conference reports, Women's health, Pregnancy.

Contraceptive choices among a Canadian cohort of HIV positive women

1 February 2014. Related: Conference reports, Women's health.

Bone disease and older HIV positive women

1 February 2014. Related: Conference reports, Women's health.

Lower immune response to the qHPV vaccine in HIV positive girls

1 February 2014. Related: Conference reports, Women's health, Paediatric care.

Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness

1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.

Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load

1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.

Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA

1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.

Lopinavir/ritonavir in pregnancy: results from a systematic review

1 February 2013. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Possible mechanisms for adverse pregnancy outcomes in HIV positive women

1 February 2013. Related: Conference reports, Women's health, Pregnancy.

Hormonal contraception and the risk of HIV acquisition

1 October 2012. Related: Conference reports, Women's health.

Intimate partner violence towards HIV positive women in the UK

1 June 2012. Related: Conference reports, Women's health.

Hormonal contraception: HIV transmission and progression rates

1 June 2012. Related: Conference reports, Women's health.

Darunavir use during pregnancy

1 June 2012. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.

The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women

1 February 2012. Related: Conference reports, Antiretrovirals, Women's health.

Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort

1 February 2012. Related: Conference reports, Women's health.

Atazanavir in pregnancy: 155 cases in London clinics

1 May 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Lopinavir/ritonavir: women versus men

1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.

Quality of life in the GRACE study

1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.

Antiretroviral pharmacokinetics in women with undetectable viral load

1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.

No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy

1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Lipodystrophy and metabolic complications.

The impact of antiretroviral treatment on fertility intentions in South Africa

1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

Cotrimoxazole with or without sulfadoxine-pyrimethamine reduces malaria in pregnant women

1 February 2011. Related: Women's health, Pregnancy.

Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg

1 October 2010. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.

HPV-based screen-and-treat is effective for cervical cancer prevention in HIV-positive women

1 October 2010. Related: Women's health, Cancer and HIV.

Genital tract viral load in women with below detectable plasma viral load

1 October 2010. Related: Women's health.

Lime juice is not a microbicide: do not try at home

26 August 2010. Related: Conference reports, Women's health, HIV prevention and transmission.

Maternal TB, HIV and pregnancy

2 April 2010. Related: Conference reports, Women's health, Pregnancy, TB coinfection.

Central fat accumulation remains a significant problem in patients starting HAART after 2005 with higher incidence in women compared to men

21 February 2010. Related: Conference reports, Women's health, Side effects, Lipodystrophy and metabolic complications.

No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

21 February 2010. Related: Conference reports, Women's health, PK and drug interactions.

Gender-based differences in patients receiving antiretroviral therapy

21 February 2010. Related: Conference reports, Women's health.

Post navigation